Elaine L. Towle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Elaine L. Towle has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Thomas R. Barr
Oncology Metrics, a division of Flatiron Health, New York, NY
5 shared publicationsJames L. Senese
Oncology Metrics, a division of Flatiron Health, New York, NY
2 shared publicationsAmy Hanley
Oncology Metrics, a division of Altos Solutions, Los Altos, CA; American Society of Clinical Oncology, Alexandria, VA; Scripps Clinic, La Jolla, CA; Hematology Oncology Associates of Illinois, Chicago, IL; Beth Israel Deaconess Medical Center, Boston, MA
1 shared publication- Dean H. Gesme1 shared publication
- Marian Wiseman
Minnesota Oncology, Minneapolis, MN; Wiseman Communications, Washington, DC
1 shared publication Michael A. Goldstein
Oncology Metrics, a division of Altos Solutions, Los Altos, CA; American Society of Clinical Oncology, Alexandria, VA; Scripps Clinic, La Jolla, CA; Hematology Oncology Associates of Illinois, Chicago, IL; Beth Israel Deaconess Medical Center, Boston, MA
1 shared publication
Latest Publications
- 1 November 2014
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 10 (6) , 407-410
Oncology Practice Trends From the National Practice Benchmark
- 1 November 2014
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 10 (6) , 407-410
Oncology Practice Trends From the National Practice Benchmark
- 1 November 2014
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 10 (6) , 385-406
The National Practice Benchmark for Oncology, 2014 Report on 2013 Data
The National Practice Benchmark (NPB) is a unique tool to measure oncology practices against others across the country in a way that allows meaningful comparisons despite differences in practice size or setting. In today's economic environment every oncology practice, regardless of business structure or affiliation, should be able to produce, monitor, and benchmark basic metrics to meet current business pressures for increased efficiency and efficacy of care. Although we recognize that the NPB survey results do not capture the experience of all oncology practices, practices that can and do participate demonstrate exceptional managerial capability, and this year those practices are recognized for their participation. In this report, we continue to emphasize the methodology introduced last year in which we reported medical revenue net of the cost of the drugs as net medical revenue for the hematology/oncology product line. The effect of this is to capture only the gross margin attributable to drugs as revenue. New this year, we introduce six measures of clinical data density and expand the radiation oncology benchmarks.
- 1 November 2014
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 10 (6) , 385-406
The National Practice Benchmark for Oncology, 2014 Report on 2013 Data
The National Practice Benchmark (NPB) is a unique tool to measure oncology practices against others across the country in a way that allows meaningful comparisons despite differences in practice size or setting. In today's economic environment every oncology practice, regardless of business structure or affiliation, should be able to produce, monitor, and benchmark basic metrics to meet current business pressures for increased efficiency and efficacy of care. Although we recognize that the NPB survey results do not capture the experience of all oncology practices, practices that can and do participate demonstrate exceptional managerial capability, and this year those practices are recognized for their participation. In this report, we continue to emphasize the methodology introduced last year in which we reported medical revenue net of the cost of the drugs as net medical revenue for the hematology/oncology product line. The effect of this is to capture only the gross margin attributable to drugs as revenue. New this year, we introduce six measures of clinical data density and expand the radiation oncology benchmarks.
- 1 November 2012
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 8 (6S) , 51s-70s
National Oncology Practice Benchmark, 2012 Report on 2011 Data
In this, the seventh iteration of the National Practice Benchmark, the authors made significant changes in the approach and analysis of the survey, including restructuring and shortening the survey instrument to facilitate the participation of hospital and academic oncology practices, in recognition of the ongoing changes in the oncology industry.
- 1 November 2012
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 8 (6S) , 51s-70s
National Oncology Practice Benchmark, 2012 Report on 2011 Data
In this, the seventh iteration of the National Practice Benchmark, the authors made significant changes in the approach and analysis of the survey, including restructuring and shortening the survey instrument to facilitate the participation of hospital and academic oncology practices, in recognition of the ongoing changes in the oncology industry.
- 1 September 2011
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 7 (5) , 278-282
Results of the ASCO Study of Collaborative Practice Arrangements
The supply of oncologists is predicted to fall short of demand in decades to come. Addressing this workforce shortage by employing nonphysician practitioners as a routine part of practice can substantially benefit both patients and providers.
- 1 September 2011
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 7 (5) , 278-282
Results of the ASCO Study of Collaborative Practice Arrangements
The supply of oncologists is predicted to fall short of demand in decades to come. Addressing this workforce shortage by employing nonphysician practitioners as a routine part of practice can substantially benefit both patients and providers.
- Open Access
- 1 September 2010
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 6 (5) , 228-231
National Practice Benchmark: 2010 Report on 2009 Data
Results from this survey indicate an overall lowering of the cost of practice operations, even as cost of drugs continues to rise; and an overall increase in service delivery efficiency.
- 1 September 2010
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 6 (5) , 228-231
Open AccessNational Practice Benchmark: 2010 Report on 2009 Data
Results from this survey indicate an overall lowering of the cost of practice operations, even as cost of drugs continues to rise; and an overall increase in service delivery efficiency.
- 1 March 2010
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 6 (2) , 104-106
Essentials of Staff Development and Why You Should Care
Physicians may reason that their energy, education, and training should be focused on patient care and research, whereas staff education should be the responsibility of practice managers. But physicians have an important role in staff development.
- 1 March 2010
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 6 (2) , 104-106
Essentials of Staff Development and Why You Should Care
Physicians may reason that their energy, education, and training should be focused on patient care and research, whereas staff education should be the responsibility of practice managers. But physicians have an important role in staff development.
- 1 September 2009
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 5 (5) , 223-227
2009 National Practice Benchmark: Report on 2008 Data
Many oncology practices have responded to rising supply costs and decreasing reimbursements by examining their operational processes and working to reduce costs and enhance practice efficiency.
- 1 September 2009
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 5 (5) , 223-227
2009 National Practice Benchmark: Report on 2008 Data
Many oncology practices have responded to rising supply costs and decreasing reimbursements by examining their operational processes and working to reduce costs and enhance practice efficiency.